Type 2 diabetes care has progressed from basic insulin use to personalized treatments like GLP-1 agonists and continuous monitoring. Advances now focus on overall health, improved management, and future innovations like gene therapy.

Direct Care fixes common primary care frustrations by limiting patient panels, allowing for longer visits and direct physician access. While it requires out-of-pocket costs, many find the convenience, personalized care, and reduced reliance on insurance a worthwhile trade-off.